A

Argenx

Organization

Heard in 4 episodes across 1 show since Jul 2026

Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. The company focuses on the development of antibody therapies for the treatment of autoimmune diseases and cancer, with a primary emphasis on orphan drugs.

Learn more

Episodes

4
across 1 show

First heard

Jul 2026

Expert statements

5
5 positive

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20261
Aug 20263
Sep 20260
Oct 20260

What experts have said about Argenx

5 statements · 5 positive

  1. Louise MoonPositiveAug 17, 2026· Stock Movers

    Argenx shares rose as much as 10%.

    “shares up as much as 10%.”

    Listen at 2:45

    Open the episode · Fresnillo AstraZeneca Climbs, Argenx Surges
  2. Louise MoonPositiveAug 17, 2026· Stock Movers

    Argenx's drug helps patients with an immune-system disease.

    “this helps patients with an immune system disease.”

    Listen at 2:53

    Open the episode · Fresnillo AstraZeneca Climbs, Argenx Surges
  3. Louise MoonPositiveAug 17, 2026· Stock Movers

    Argenx shares rose by as much as 10%.

    “shares up as much as 10%.”

    Listen at 3:00

    Open the episode · Fresnillo AstraZeneca Climbs, Argenx Surges
See all 5 statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

4 episodes featuring Argenx, newest first

Argenx · PodLume